Effect of Pasifika Intervention on uptake of urate-lowering therapy

Not Applicable

• Conditions: Gout; Gout management - Lower uptake of urate-lowering therapy (allopurinol ) among Pacific; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12622000278730
• Lead Sponsor: Dr Malakai Ofanoa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-15
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

All patients aged 20 years or older with a diagnosis of gout.

Exclusion Criteria

Participants who were not meeting the study gout criteria/classification (SUA levels <360 µmol/L)
Participants aged <20 years.
Participants who are not able to give to consent.
Participants with a terminal or severe illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Regular prescriptions of gout specific urate lowering therapy determined by data linkage to medical records.[3 months post-enrolment; 9 months post-intervention];Serum urate testing results during the evaluation period determined by data linkage to medical records.[3 months post-enrolment; 9 months post-intervention];Hospitalisations for gout determined by data linkage to medical records.[3 months post-enrolment; 9 months post-intervention]